BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
55 results:

  • 1. eif4a3-induced circular RNA SCAP facilitates tumorigenesis and progression of non-small-cell lung cancer via miR-7/SMAD2 signaling.
    Zhang Y; Qi W; Wu Y
    Environ Sci Pollut Res Int; 2023 May; 30(24):65237-65249. PubMed ID: 37079240
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
    Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
    Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
    Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
    Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
    Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
    J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Role of eukaryotic translation initiation factor 4G in tumor].
    Zhang S; Huang N; Pan X; Zang JL; Guan XX; Zhang JH; Liu LC; Lei XY
    Sheng Li Xue Bao; 2016 Apr; 68(2):207-14. PubMed ID: 27108909
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.
    Crane CH; Koay EJ
    Cancer; 2016 Jul; 122(13):1974-86. PubMed ID: 26950735
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell lung cancer: A Meta-Analysis of Published Data.
    Wang Y; Gao W; Xu J; Chen X; Yang Y; Zhu Y; Yin Y; Guo R; Liu P; Shu Y; Liu L
    Biomed Res Int; 2015; 2015():763080. PubMed ID: 26788508
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection.
    Li D; Meng Q; Zhang H; Feng T; Liu M; Cai L
    Tumour Biol; 2016 Apr; 37(4):4393-8. PubMed ID: 26499943
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Treatment and prognosis of the carcinoma arising from nasal and sinonasal inverted papilloma: report of 62 cases and systematic review].
    Liang Q; Wu Y; Li D; Xu Z
    Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):133-7. PubMed ID: 25975691
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chemotherapy versus best supportive care for extensive small cell lung cancer.
    Pelayo Alvarez M; Westeel V; Cortés-Jofré M; Bonfill Cosp X
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001990. PubMed ID: 24282143
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma].
    Meng HM; Yang YF; Qi LQ; Gu L
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):525-9. PubMed ID: 24257306
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Downregulation of eif4a2 in non-small-cell lung cancer associates with poor prognosis.
    Shaoyan X; Juanjuan Y; Yalan T; Ping H; Jianzhong L; Qinian W
    Clin Lung Cancer; 2013 Nov; 14(6):658-65. PubMed ID: 23867391
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372.
    Lai JH; She TF; Juang YM; Tsay YG; Huang AH; Yu SL; Chen JJ; Lai CC
    Electrophoresis; 2012 Feb; 33(4):675-88. PubMed ID: 22451061
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer.
    Li Y; Fan S; Koo J; Yue P; Chen ZG; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
    Cancer Biol Ther; 2012 Mar; 13(5):272-80. PubMed ID: 22236867
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Chemotherapy versus best supportive care for extensive small cell lung cancer.
    Pelayo Alvarez M; Gallego Rubio O; Bonfill Cosp X; Agra Varela Y
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001990. PubMed ID: 19821287
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chemotherapy versus best supportive care for extensive small cell lung cancer.
    Agra Y; Pelayo M; Sacristan M; Sacristán A; Serra C; Bonfill X
    Cochrane Database Syst Rev; 2003; (4):CD001990. PubMed ID: 14583943
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents.
    Fiotti N; Altamura N; Cappelli C; Schillan M; Guarnieri G; Giansante C
    Eur J Vasc Endovasc Surg; 2003 Oct; 26(4):374-80. PubMed ID: 14511998
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Considerations about the complete resection in NSCLC surgery. Review.
    Carbone E; Spinelli E; Droz Blanc C; Cascino QR; Motta G
    Ann Ital Chir; 2002; 73(4):365-74. PubMed ID: 12661224
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients.
    Wroński M; Arbit E
    J Neurosurg; 2000 Jul; 93(1):9-18. PubMed ID: 10883899
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Second malignancies after Hodgkin's disease: the Munich experience.
    Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
    Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.